A, the carbonic anhydrase inhibitor acetazolamide (100 μmol l−1) abolished forskolin-stimulated secretion (n= 6). B, sequential addition of the NHE inhibitors HOE694 (10 μmol l−1) and amiloride (1 mmol l−1) to the basolateral side had no effect on Ieq or HCO3− secretion (n= 3). C, acetazolamide caused a small reduction in forskolin-stimulated fluid secretion by Calu-3 cells. •, Ieq; º, HCO3− secretion. ▪, without acetazolamide; ▴, with acetazolamide (n= 6). Means ± SEM.